RxDoctor Payments Data

Wendell Richards, DO

Family Medicine · Chandler, OKNPI 1588656292

Payments from drug & device makers

$484in general payments, 2019–2025

Across 25 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$212
  • Electromed, Inc.$62
  • Lilly USA, LLC$50
  • Pfizer$34
  • Johnson & Johnson$26
  • Eisai Inc.$22
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$484 in reported general payments places this provider in the 50th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$111,556
Medicare patients
337
Services billed
3,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide112$136,642
JardianceEmpagliflozin73$80,395
EliquisApixaban72$72,931
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$53,952
JanuviaSitagliptin Phosphate33$43,387
TrulicityDulaglutide29$39,940
MounjaroTirzepatide29$39,718
XareltoRivaroxaban48$35,513
FarxigaDapagliflozin Propanediol27$26,035
OxycontinOxycodone Hcl25$19,342
Combivent RespimatIpratropium/Albuterol Sulfate31$14,388
Breo ElliptaFluticasone/Vilanterol35$14,034
EntrestoSacubitril/Valsartan12$13,136
Xigduo XrDapaglifloz Propaned/Metformin15$11,632
AbrysvoRsv Vacc, Pref A And Pref B/Pf36$10,931

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$136,642112 claims
PfizerEliquis, Abrysvo$34$83,862108 claims
Lilly USA, LLCTrulicity, Mounjaro$50$79,65758 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$16$72,343115 claims
Johnson & JohnsonXarelto$26$35,51348 claims
AstraZenecaFarxiga$212$26,03527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Chandler

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →